Volver a Agenda
Session Chair(s)
Ann Meeker-O'Connell, MS
Executive Director, Monitoring Excellence Head
Novartis, United States
Learning Objective : Discuss emerging technologies including the potential benefits of adopting patient-centric technology; Explain the potential challenges in implementation as well as compliance considerations in meeting applicable laws and regulations.
Speaker(s)
Regulatory Perspective
Sean Kassim, PHD
FDA, United States
Director, Office of Study Integrity and Surveillance, OTS, CDER
Industry Perspective
Coleen Glessner, MBA
Alexion Pharmaceuticals, United States
Senior Vice President, Chief Quality Officer
Patient Perspective
Marcia K. Horn, JD
ICAN, International Cancer Advocacy Network, United States
President and CEO
¿Tiene una cuenta?